Impact of different infliximab dose regimens on treatment response and drug survival in 462 patients with SpA. Results from the nationwide registries DANBIO and ICEBIO.

Bente Glintborg; B. Gudbjornsson; Niels Steen Krogh; E. Omerovic; N. Manilo; M. Holland-Fischer; H. Lindegaard; A.G Loft; H. Nordin; L. Johnsen; S.F. Oeftiger; A. Hansen; C. Rasmussen; G. Grondal; A.J. Geirsson; Merete Lund Hetland

Impact of different infliximab dose regimens on treatment response and drug survival in 462 patients with SpA. Results from the nationwide registries DANBIO and ICEBIO.

Bente Glintborg, B. Gudbjornsson, Niels Steen Krogh, E. Omerovic, N. Manilo, M. Holland-Fischer, H. Lindegaard, A.G Loft, H. Nordin, L. Johnsen, S.F. Oeftiger, A. Hansen, C. Rasmussen, G. Grondal, A.J. Geirsson, Merete Lund Hetland

Afdeling for Rygkirurgi, Led- og Bindevævssygdomme

Originalsprog	Engelsk
Tidsskrift	Annals of the Rheumatic Diseases
Vol/bind	73
Udgave nummer	Suppl. 2
Sider (fra-til)	89
Antal sider	1
ISSN	0003-4967
Status	Udgivet - 2014

Citationsformater

Glintborg, B., Gudbjornsson, B., Krogh, N. S., Omerovic, E., Manilo, N., Holland-Fischer, M., Lindegaard, H., Loft, A. G., Nordin, H., Johnsen, L., Oeftiger, S. F., Hansen, A., Rasmussen, C., Grondal, G., Geirsson, A. J., & Hetland, M. L. (2014). Impact of different infliximab dose regimens on treatment response and drug survival in 462 patients with SpA. Results from the nationwide registries DANBIO and ICEBIO. Annals of the Rheumatic Diseases, 73(Suppl. 2), 89.

Impact of different infliximab dose regimens on treatment response and drug survival in 462 patients with SpA. Results from the nationwide registries DANBIO and ICEBIO. / Glintborg, Bente; Gudbjornsson, B.; Krogh, Niels Steen et al.
I: Annals of the Rheumatic Diseases, Bind 73, Nr. Suppl. 2, 2014, s. 89.

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

Glintborg, B, Gudbjornsson, B, Krogh, NS, Omerovic, E, Manilo, N, Holland-Fischer, M, Lindegaard, H, Loft, AG, Nordin, H, Johnsen, L, Oeftiger, SF, Hansen, A, Rasmussen, C, Grondal, G, Geirsson, AJ & Hetland, ML 2014, 'Impact of different infliximab dose regimens on treatment response and drug survival in 462 patients with SpA. Results from the nationwide registries DANBIO and ICEBIO.', Annals of the Rheumatic Diseases, bind 73, nr. Suppl. 2, s. 89.

@article{322d977291b84705879fbe28d82597cc,

title = "Impact of different infliximab dose regimens on treatment response and drug survival in 462 patients with SpA. Results from the nationwide registries DANBIO and ICEBIO.",

author = "Bente Glintborg and B. Gudbjornsson and Krogh, {Niels Steen} and E. Omerovic and N. Manilo and M. Holland-Fischer and H. Lindegaard and A.G Loft and H. Nordin and L. Johnsen and S.F. Oeftiger and A. Hansen and C. Rasmussen and G. Grondal and A.J. Geirsson and Hetland, {Merete Lund}",

year = "2014",

language = "English",

volume = "73",

pages = "89",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "Elsevier BV",

number = "Suppl. 2",

}

TY - ABST

T1 - Impact of different infliximab dose regimens on treatment response and drug survival in 462 patients with SpA. Results from the nationwide registries DANBIO and ICEBIO.

AU - Glintborg, Bente

AU - Gudbjornsson, B.

AU - Krogh, Niels Steen

AU - Omerovic, E.

AU - Manilo, N.

AU - Holland-Fischer, M.

AU - Lindegaard, H.

AU - Loft, A.G

AU - Nordin, H.

AU - Johnsen, L.

AU - Oeftiger, S.F.

AU - Hansen, A.

AU - Rasmussen, C.

AU - Grondal, G.

AU - Geirsson, A.J.

AU - Hetland, Merete Lund

PY - 2014

Y1 - 2014

M3 - Conference abstract in journal

SN - 0003-4967

VL - 73

SP - 89

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

IS - Suppl. 2

ER -